Moderna Stock ($MRNAon ) Rises Over 12%! Here is Why 👇
Moderna stock jumped a massive 12.59% on Friday, closing at $67.27! Here are the 2 main reasons behind this huge surge:
1️⃣ FDA Panel Approval: The US FDA advisory committee unanimously voted 9-0, recommending Moderna's new mRNA-based seasonal flu vaccine (mFlusiva). They agreed that its benefits far outweigh the risks.
2️⃣ High Efficacy: Phase 3 trials showed this new vaccine is 26.6% to 27% more effective than traditional egg-based flu shots.
This is a big win for mRNA technology! 🚀
Urdu summary:
Moderna’s stock rose more than 12% on Friday to close higher. The reason for this big surge is their new flu vaccine (mFlusiva), which the US FDA panel has unanimously recommended for approval. This new vaccine has proven to be 27% more effective than older vaccines.
#ModernaRisesOver12% #Moderna
#stockmarket #CryptoNewss #BinanceSquare
Moderna stock jumped a massive 12.59% on Friday, closing at $67.27! Here are the 2 main reasons behind this huge surge:
1️⃣ FDA Panel Approval: The US FDA advisory committee unanimously voted 9-0, recommending Moderna's new mRNA-based seasonal flu vaccine (mFlusiva). They agreed that its benefits far outweigh the risks.
2️⃣ High Efficacy: Phase 3 trials showed this new vaccine is 26.6% to 27% more effective than traditional egg-based flu shots.
This is a big win for mRNA technology! 🚀
Urdu summary:
Moderna’s stock rose more than 12% on Friday to close higher. The reason for this big surge is their new flu vaccine (mFlusiva), which the US FDA panel has unanimously recommended for approval. This new vaccine has proven to be 27% more effective than older vaccines.
#ModernaRisesOver12% #Moderna
#stockmarket #CryptoNewss #BinanceSquare